VCP
ANTH

Verus Capital Partners’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Verus Capital Partners’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed – – 1655
2019
Q4 		$0 Buy
+2,000
New – ﹤0.01% 1567

Verus Capital Partners's ANTH Position: Q1 2020 in Review

Verus Capital Partners sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2020, closing a stake of 2,000 shares.

Verus Capital Partners first reported a position in ANTH in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 0 funds tracked by Wall St. Rank hold ANTH as of Q1 2020.

  • Verus Capital Partners reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Verus Capital Partners sold 2,000 Anthera Pharmaceuticals, Inc. shares in Q1 2020.
  • Verus Capital Partners first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2019 and held it in 1 quarter.
  • Verus Capital Partners's Anthera Pharmaceuticals, Inc. position peaked at $0 in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.